eScholarship
metadata only
Discovering a Novel AAV2-Based Capsid for RPE Transduction via Intravitreal Injection in rd12 Mice for Leber Congenital Amaurosis Type 2 Gene Therapy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Trial of Gene Therapy for the Treatment of Leber Congenital Amaurosis (LCA)#883898
- Treatment With Interferon-Α2B And Ribavirin Improves Outcome In MERS-CoV–infected Rhesus Macaques#19583
- Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists.#13627
- The NTR/prodrug revolution: Tools for controlling cell loss and regeneration.#265446
- Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis#849647
Record · ID 634876
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive